SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-030903
Filing Date
2019-08-08
Accepted
2019-08-08 17:08:41
Documents
4
Period of Report
2019-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20190805.htm 8-K 54368
2 EX-2.1 insy-ex21_8.htm EX-2.1 505785
3 EX-2.2 insy-ex22_7.htm EX-2.2 494798
4 EX-99.1 insy-ex991_6.htm EX-99.1 30303
  Complete submission text file 0001564590-19-030903.txt   1086421
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 191010511
SIC: 2834 Pharmaceutical Preparations